COVID-19 vaccine and non-syndromic orofacial clefts in five arab countries. A case-control study

期刊论文
发表日期：

2024年6月6日

查看全文

Rana A. Alamoudi,
Heba Jafar Sabbagh,
Mohammad Zeinalddin,
Ola B. Al-Batayneh,
Taimoor Al Bulushi,
Mamdouh A. AboulHassan,
Mohamed Koraitim,
Lateefa Alkharafi,
Buthaina Almuqbali,
Sultan Musaad Alghamdi,
Dania Bahdila,
Shaimaa Mohsen Refahee,
Maryam Quritum,
Fatemah Fahad Taqi,
Bader Albassam,
Mariam Ayed,
Alia Embaireeg,
Raqiya Alnahdi,
Mona Talal AlSharif,
Aziza Johar Aljohar,
Fatma Dawood Abdulhameed,
Najla Sulaiman Alrejaye,
P S Viswapurna,
Tamara Al Halasa,
Osama Adel Basri,
Mohammed A. Bataineh,
Maha El Tantawi

摘要

Objectives

Risk factors for non-syndromic orofacial cleft (NSOFCs) include genetic profile and environmental exposure to medication and illnesses during pregnancy. We assessed the association between the COVID-19 vaccination and the incidence of NSOFC across five Middle Eastern countries.

Materials and methods

This multi-country, hospital-based, case-control study included infants with NSOFCs whose first 3 intrauterine months coincided with the time when pregnant women were allowed to receive COVID-19 vaccination in the countries participating in the study. Newborns with NSOFCs were examined for cleft type and their parents were interviewed for maternal exposures and COVID-19 vaccination. Controls were newborns matched to cases in gender and setting.

Results

The study recruited 977 (348 children with NSOFCs and 629 controls). Maternal use of nicotine (Adjusted Odds Ratio (AOR): 2.437; P = 0.044) and family history of NSOFC (AOR: 11.059; P < 0.001) increased significantly the AOR of having a child with NSOFC. On the other hand, COVID-19 vaccine administration to pregnant mothers have significantly decreased the AOR of having a child with NSOFC (AOR: 0.337; P = 0.006).

Conclusion

This study suggests that COVID-19 vaccination is not related to NSOFC and might protect against having a child affected with such a congenital anomaly.

Clinical relevance

The finding of this study is important for healthcare providers for considering COVID-19 vaccination for pregnant woman. Clear communication and education about the potential risks and benefits would be crucial for informed decision-making. The study’s results would directly impact pregnant individuals, as they would need accurate information to make informed decisions about their health and the health of their infants.